Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsNASALGeneric

CALOMIST

CYANOCOBALAMIN

Standard Dose
25MCG/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview CALOMIST is listed in Drugs@FDA under application 022102 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CYANOCOBALAMIN Form and strength SPRAY, METERED;NASAL - 25MCG/SPRAY Sponsor PH HEALTH Submission history Latest submission status date: 2020-01-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview CALOMIST is listed in Drugs@FDA under application 022102 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CYANOCOBALAMIN Form and strength SPRAY, METERED;NASAL - 25MCG/SPRAY Sponsor PH HEALTH Submission history Latest submission status date: 2020-01-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.